These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 860079)

  • 1. [Chronic aggressive hepatitis with low and normal serum complement levels].
    Díaz-Rubio Garcia M; Enríquez L; Díaz-Rubio garcía E
    Rev Esp Enferm Apar Dig; 1977 Apr; 50(1):31-6. PubMed ID: 860079
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of complement (C3) levels in acute hepatitis and chronic liver diseases].
    Soerensen R; Carmona A; Meléndez M; Velasco M
    Rev Med Chil; 1971 Sep; 99(9):630-40. PubMed ID: 5157211
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior of the 3rd and 4th complement fractions in chronic hepatitis].
    Díaz-Rubio García M; Erroz A; Enríquez L; Arroyo MJ; Zamarrón A; Diáz Rubio M
    Rev Clin Esp; 1974 Aug; 134(3):237-42. PubMed ID: 4216050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Status of various factors of the complement system in chronic and acute hepatitis].
    Del Rey Calero J; Garcia de Lomas J; Gómez Morillo O; García de Lomas E; Miño G
    Rev Clin Esp; 1976 Jun; 141(6):515-23. PubMed ID: 968086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological aspects of aggressive chronic hepatitis].
    Gioannini P
    Recenti Prog Med; 1971 Apr; 50(4):371-89. PubMed ID: 5316056
    [No Abstract]   [Full Text] [Related]  

  • 7. [The C3, C3 Att and C4 fractions of complement in chronic hepatitis: preliminary data].
    Riegler G; Ciotola R; Di Simone A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(4):200-3. PubMed ID: 952675
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of serum complement levels in chronic liver disease.
    Finlayson ND; Krohn K; Fauconnet MH; Anderson KE
    Gastroenterology; 1972 Oct; 63(4):653-9. PubMed ID: 4116547
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical considerations on some cases of aggressive chronic hepatitis].
    Uccella R
    Minerva Med; 1973 Aug; 64(57):2992-5. PubMed ID: 4742638
    [No Abstract]   [Full Text] [Related]  

  • 10. BA and SH antigen in chronic hepatitis.
    Grob PJ; Jemelka HJ; Müller JW
    Gastroenterology; 1971 Jul; 61(1):91-5. PubMed ID: 4996714
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune complexes in chronic hepatitis.
    Fodor O; Parau N; Fodor I; Radu D; Abrudan O
    Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):172-6. PubMed ID: 941620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors causing decrease in complement activity in chronic liver diseases].
    Tsuji T; Sato M; Nozaki H; Mizuno Y; Kosaka K
    Igaku To Seibutsugaku; 1970 Oct; 81(4):155-61. PubMed ID: 5531565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complement level in serum from patients with chronic hepatitis].
    Milosavljević J; Cvorić-Guzina M; Bozić M
    Bilt Hematol Transfuz; 1981; 9(1-3):113-9. PubMed ID: 7349751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative correlation between C-reactive protein and other immunity factors in hepatic diseases].
    Pérez Miranda M; Borda Celaya F; Ortíz de Landazúri E
    Rev Clin Esp; 1973 Jun; 130(1):19-28. PubMed ID: 4755582
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.
    Teisberg P; Gjone E
    Clin Exp Immunol; 1973 Aug; 14(4):509-14. PubMed ID: 4201114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune complexes in chronic hepatitis].
    Martinez-Vazquez JM; Guardia J; Bacardi R; Carrera M; Ferragut A
    Nouv Presse Med; 1972 Sep; 1(31):2031-4. PubMed ID: 4117644
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiological implications of the hepatitis associated antigen (HAA).
    Miescher PA; Portmann B; Farquet J-J
    Haematologia (Budap); 1974; 8(1-4):415-25. PubMed ID: 4156673
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum complement and hepatic diseases].
    Kourilsky O; Leroy C; Peltier AP
    Nouv Presse Med; 1973 Jun; 2(25):1720. PubMed ID: 4718548
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australia antigen and circulating antibodies in chronic aggressive hepatitis.
    Findor J; Igartua EB; Alonso A; Domecq R; Bozzola C
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):98-102. PubMed ID: 4201582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.